Refractoriness to last line of therapy : how often is it mandated and reported? A systematic review of randomized myeloma trials
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 64(2023), 7 vom: 27. Juli, Seite 1340-1343 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bindal, Poorva [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 11.01.2024 Date Revised 11.01.2024 published: Print-Electronic ErratumIn: Leuk Lymphoma. 2023 Jun 6;:1. - PMID 37278383 Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2023.2209682 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356734641 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356734641 | ||
| 003 | DE-627 | ||
| 005 | 20240114234201.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2023.2209682 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1257.xml |
| 035 | |a (DE-627)NLM356734641 | ||
| 035 | |a (NLM)37170589 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bindal, Poorva |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Refractoriness to last line of therapy |b how often is it mandated and reported? A systematic review of randomized myeloma trials |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.01.2024 | ||
| 500 | |a Date Revised 11.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Leuk Lymphoma. 2023 Jun 6;:1. - PMID 37278383 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Najjar, Mimi |e verfasserin |4 aut | |
| 700 | 1 | |a Koehn, Kelly |e verfasserin |4 aut | |
| 700 | 1 | |a Godara, Amandeep |e verfasserin |4 aut | |
| 700 | 1 | |a Sborov, Douglas W |e verfasserin |4 aut | |
| 700 | 1 | |a McClune, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Julian, Kelley |e verfasserin |4 aut | |
| 700 | 1 | |a Wagner, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Mohyuddin, Ghulam Rehman |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 64(2023), 7 vom: 27. Juli, Seite 1340-1343 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:64 |g year:2023 |g number:7 |g day:27 |g month:07 |g pages:1340-1343 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2023.2209682 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 64 |j 2023 |e 7 |b 27 |c 07 |h 1340-1343 | ||